Marréaud, S.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial

Bui-Nguyen, B., Butrynski, J.E., Penel, N., Blay, J.Y., Isambert, N., Milhem, M., Kerst, J.M., Reyners, A.K.L, Litière, S., Marréaud, S., Collin, F., van der Graaf, W.T.A

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 530 KB

english, 2015

2

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Benson, C., Ray-Coquard, I., Sleijfer, S., Litière, S., Blay, J.-Y., Le Cesne, A., Papai, Z., Judson, I., Schöffski, P., Chawla, S., Gil, T., Piperno-Neumann, S., Marréaud, S., Dewji, M.R., van der Gr

Journal:

Gynecologic Oncology

Year:

2016

Language:

english

File:

PDF, 757 KB

english, 2016

3

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for res

Coens, Corneel, van der Graaf, Winette T. A., Blay, Jean-Yves, Chawla, Sant P., Judson, Ian, Sanfilippo, Roberta, Manson, Stephanie C., Hodge, Rachel A., Marreaud, Sandrine, Prins, Judith B., Lugowska

Journal:

Year:

2015

Language:

english

File:

PDF, 225 KB

english, 2015

4

A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, Vsevolod Matveev, Aldo Bono, Andrzej Borkowski, Marc Colombel, Laurence Klotz, Eila Skinner, Thomas Keane, Sandrine Marreaud, Sandra Collette, Rich

Journal:

European Urology

Year:

2011

Language:

english

File:

PDF, 522 KB

english, 2011

5

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

Gelderblom, H., Blay, J.Y., Seddon, B.M., Leahy, M., Ray-Coquard, I., Sleijfer, S., Kerst, J.M., Rutkowski, P., Bauer, S., Ouali, M., Marreaud, S., van der Straaten, R.J.H.M., Guchelaar, H.-J., Weitma

Journal:

European Journal of Cancer

Year:

2014

Language:

english

File:

PDF, 758 KB

english, 2014

6

Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIME

Bex, A., Mulders, P., Jewett, M., Wagstaff, J., Van Velthoven, R., Laguna, P., Wood, L., Van Melick, H., Soetekouw, P., Lattouf, J., Powles, T., De Jong, I., Rottey, S., Tombal, B., Marreaud, S., Coll

Journal:

European Urology Supplements

Year:

2018

Language:

english

File:

PDF, 210 KB

english, 2018

7

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

F. Duffaud, S. Sleijfer, S. Litière, I. Ray-coquard, A. Le Cesne, Z. Papai, I. Judson, P. Schöffski, S. Chawla, R. Dewji, S. Marreaud, J. Verweij, W. Van Der Graaf

Year:

2015

Language:

english

File:

PDF, 613 KB

english, 2015

8

EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

Wagner, Anna Dorothea, Grabsch, Heike I., Mauer, Murielle, Marreaud, Sandrine, Caballero, Carmela, Thuss-Patience, Peter, Mueller, Lothar, Elme, Annelie, Moehler, Markus Hermann, Martens, Uwe, Kang, Y

Journal:

Year:

2019

Language:

english

File:

PDF, 898 KB

english, 2019

9

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

Kasper, B., Sleijfer, S., Litiere, S., Marreaud, S., Verweij, J., Hodge, R. A., Bauer, S., Kerst, J. M., van der Graaf, W. T. A.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 177 KB

english, 2014

10

A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens

Ray-Coquard, I., Le Cesne, A., Whelan, J. S., Schoffski, P., Bui, B. N., Verweij, J., Marreaud, S., van Glabbeke, M., Hogendoorn, P., Blay, J.-Y.

Journal:

Year:

2008

Language:

english

File:

PDF, 186 KB

english, 2008

11

1496PEORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy

Touati, N., Schoffski, P., Litière, S., Judson, I., Sleijfer, S., van der Graaf, W.T.A., Italiano, A., Isambert, N., Gil, T., Blay, J-Y., Stark, D., Brodowicz, T., Marreaud, S., Gronchi, A.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 47 KB

english, 2017

12

Valence band structure of very narrow InGaAs/InP quantum wells

F. Dujardin, N. Marréaud, J.P. Laurenti

Journal:

Solid State Communications

Year:

1996

Language:

english

File:

PDF, 289 KB

english, 1996

13

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study

Penel, N, Glabbeke, M V, Mathoulin-Pelissier, S, Judson, I, Sleijfer, S, Bui, B, Schoffski, P, Ouali, M, Marreaud, S, Brouste, V

Journal:

British Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 356 KB

english, 2011

14

Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial

Bojana Pajk, Tanja Cufer, Peter Canney, Paul Ellis, David Cameron, Emmanuel Blot, Jan Vermorken, Robert Coleman, Sandrine Marreaud, Jan Bogaerts, Gul Basaran, Martine Piccart

Journal:

Year:

2008

Language:

english

File:

PDF, 139 KB

english, 2008

15

Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

M.J.A. de Jonge, H. Dumez, J. Verweij, S. Yarkoni, D. Snyder, D. Lacombe, S. Marréaud, T. Yamaguchi, C.J.A. Punt, A. van Oosterom

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 162 KB

english, 2006

16

Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

Oddens, Jorg, Brausi, Maurizio, Sylvester, Richard, Bono, Aldo, van de Beek, Cees, van Andel, George, Gontero, Paolo, Hoeltl, Wolfgang, Turkeri, Levent, Marreaud, Sandrine, Collette, Sandra, Oosterlin

Journal:

European Urology

Year:

2013

Language:

english

File:

PDF, 1.04 MB

english, 2013

17

Randomized Phase III Study Comparing Paclitaxel-Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983

de Wit, R., Skoneczna, I., Daugaard, G., De Santis, M., Garin, A., Aass, N., Witjes, A. J., Albers, P., White, J. D., Germa-Lluch, J. R., Marreaud, S., Collette, L.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 174 KB

english, 2012

18

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)

Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C., Schmoll, H. J.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

19

Using the continual reassessment method: Lessons Learned from an EORTC phase I dose finding study

Xavier Paoletti, Benoît Baron, Patrick Schöffski, Pierre Fumoleau, Denis Lacombe, Sandrine Marreaud, Richard Sylvester

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 185 KB

english, 2006

20

50 years of the EORTC and the central role of the EORTC Headquarters

Denis Lacombe, John Bean, Jan Bogaerts, Andrew Bottomley, Laurence Collette, Caroline Gilotay, Ann Marinus, Sandrine Marréaud, Pascal Ruyskart, Richard Sylvester, Françoise Meunier

Journal:

European Journal of Cancer Supplements

Year:

2012

Language:

english

File:

PDF, 398 KB

english, 2012

21

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)

Fumoleau, Pierre, Koch, Kevin M., Brain, Etienne, Lokiec, François, Rezai, Keyvan, Awada, Ahmad, Hayward, Larry, Werutsky, Gustavo, Bogaerts, Jan, Marréaud, Sandrine, Cardoso, Fatima

Journal:

Year:

2014

Language:

english

File:

PDF, 727 KB

english, 2014

22

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)

Theodore, C., Skoneczna, I., Bodrogi, I., Leahy, M., Kerst, J. M., Collette, L., Ven, K., Marreaud, S., Oliver, R. D. T.

Journal:

Annals of Oncology

Year:

2008

Language:

english

File:

PDF, 73 KB

english, 2008

23

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

Lothar Bergmann, Steiner Aamdal, Sandrine Marreaud, Denis Lacombe, Manfred Herold, Takuhiro Yamaguchi, Karin Wilhelm-Ogunbiyi, Hans Lentzen, Heinz Zwierzina

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 160 KB

english, 2008

24

Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer "Unfit" for Cisplatin-Based Chemotherapy: Phase II--Results of EORTC Study 30986

De Santis, M., Bellmunt, J., Mead, G., Kerst, J. M., Leahy, M., Maroto, P., Skoneczna, I., Marreaud, S., de Wit, R., Sylvester, R.

Journal:

Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 120 KB

english, 2009

25

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

De Santis, M., Bellmunt, J., Mead, G., Kerst, J. M., Leahy, M., Maroto, P., Gil, T., Marreaud, S., Daugaard, G., Skoneczna, I., Collette, S., Lorent, J., de Wit, R., Sylvester, R.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 161 KB

english, 2012

26

Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group

M. Schlemmer, P. Reichardt, J. Verweij, J.T. Hartmann, I. Judson, A. Thyss, P.C.W. Hogendoorn, S. Marreaud, M. Van Glabbeke, J.Y. Blay

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 102 KB

english, 2008

27

9400 ORAL Prognostic and Predictive Factors in Advanced Soft Tissue Sarcoma Patients Treated in an EORTC STBSG Global Network Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo (EORTC 62072, PALETTE)

Van der Graaf, W.T.A., Blay, J.Y., Chawla, S., Kim, D.W., Bui-Nguyen, B., Van Glabbeke, M., Marreaud, S., Pandite, L., Dei Tos, P., berger, P. Hohen

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 43 KB

english, 2011

28

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy

Ray-Coquard, I., Rizzo, E., Blay, J.Y., Casali, P., Judson, I., Hansen, A. Krarup, Lindner, L.H., dei Tos, A.P., Gelderblom, H., Marreaud, S., Litière, S., Rutkowski, P., Hohenberger, P., Gronchi, A.,

Journal:

Gynecologic Oncology

Year:

2016

Language:

english

File:

PDF, 533 KB

english, 2016

29

Impact of acute kidney injury on anticancer treatment dosage and long-term outcomes: a pooled analysis of European Organisation for Research and Treatment of Cancer trials

PÃ©ron, Julien, Neven, Anouk, Collette, Laurence, Launay-Vacher, Vincent, Sprangers, Ben, Marreaud, Sandrine

Journal:

Nephrology Dialysis Transplantation

Year:

2020

File:

PDF, 763 KB

2020

30

Low incidence of cardiac events in an EORTC phase II study of CMF in combination with trastuzumab in women with HER-2 positive metastatic breast cancer

D. Cameron, Marreaud, Z. Neskovic-Konstantinovic, S. Omar, M. Nooij, B. De Valk, J. Bogaerts, P. Therasse

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 140 KB

english, 2006

31

275 Taxanes in angiosarcomas

M. Schlemmer, P. Reichardt, J. Verweij, J. Hartmann, I. Judson, A. Thyss, P.C.W. Hogendoorn, S. Marreaud, M. Van Glabbeke

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 45 KB

english, 2009

32

3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)

Lindner, L., Litiere, S., Sleijfer, S., Judson, I., Italiano, A., Kasper, B., Gelderblom, H., Marreaud, S., Wardelmann, E., Gronchi, A., Graaf, W. Van der

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 64 KB

english, 2015

33

Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis

Kollar, A., Jones, R.L., Stacchiotti, S., Gelderblom, H., Guida, M., Boccone, P., Steeghs, N., Safwat, A., Katz, D., Duffaud, F., Sleijfer, S., van sder Graaf, W., Touati, N., Litière, S., Marreaud, S

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 43 KB

english, 2016

34

European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy

Touati, N., Schöffski, P., Litière, S., Judson, I., Sleijfer, S., van der Graaf, W.T., Italiano, A., Isambert, N., Gil, T., Blay, J.Y., Stark, D., Brodowicz, T., Marréaud, S., Gronchi, A.

Journal:

Clinical Oncology

Year:

2018

Language:

english

File:

PDF, 515 KB

english, 2018

35

Electronic structure of interdiffused GaInAs(P)/GaInAsP quantum wells

J.-P. Laurenti, O. Pagès, N. Marréaud

Journal:

Computational Materials Science

Year:

2000

Language:

english

File:

PDF, 266 KB

english, 2000

36

366 POSTER Phase I study of NGR-TNF, a novel vascular targeting agent, in patients with refractory solid tumours (EORTC 16041)

C. Van Herpen, W. Fiedler, S. Toma, S. Marreaud, H. Van Laarhoven, P. Lasch, J. Bogaerts, A. Heerschap, C. Bordignon, C. Punt

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

37

Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years

Penel, N., Van Glabbeke, M., Marreaud, S., Ouali, M., Blay, J. Y., Hohenberger, P.

Journal:

Annals of Oncology

Year:

2011

Language:

english

File:

PDF, 159 KB

english, 2011

38

Angiosarcoma: State of the art and perspectives

Nicolas Penel, Sandrine Marréaud, Yves-Marie Robin, Peter Hohenberger

Journal:

Critical Reviews in Oncology/Hematology

Year:

2011

Language:

english

File:

PDF, 225 KB

english, 2011

39

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

Bellmunt, J., von der Maase, H., Mead, G. M., Skoneczna, I., De Santis, M., Daugaard, G., Boehle, A., Chevreau, C., Paz-Ares, L., Laufman, L. R., Winquist, E., Raghavan, D., Marreaud, S., Collette, S.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 182 KB

english, 2012

40

Trial design on prophylaxis and treatment of brain metastases: Lessons learned from the EORTC Brain Metastases Strategic Meeting 2012

Matthias Preusser, Frank Winkler, Laurence Collette, Sven Haller, Sandrine Marreaud, Riccardo Soffietti, Martin Klein, Jaap C. Reijneveld, Jörg-Christian Tonn, Brigitta G. Baumert, Paula Mulvenna, Dir

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 609 KB

english, 2012

41

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial

Pasquali, Sandro, Pizzamiglio, Sara, Touati, Nathan, Litiere, Saskia, Marreaud, Sandrine, Kasper, Bernd, Gelderblom, Hans, Stacchiotti, Silvia, Judson, Ian, Dei Tos, Angelo P., Verderio, Paolo, Casali

Journal:

European Journal of Cancer

Year:

2019

File:

PDF, 1000 KB

2019

42

5073 Lapatax: Safety profile of neoadjuvant lapatinib combined with docetaxel in Her 2/neu overexpressing breast cancer – EORTC protocol 10054

H. Bonnefoi, K. Zaman, M. Nobaher, E. Brain, J.Y. Pierga, K.M. Koch, J. Bartlett, S. Marreaud, J. Bogaerts, D. Cameron

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

43

Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061

Cerbone, Linda, Sternberg, Cora N., Sengel�v, Lisa, Agerbaek, Mads, Van Herpen, Carla, Marreaud, Sandrine, Collette, Sandra, Zhang, Jianping, Daugaard, Gedske

Journal:

Year:

2015

Language:

english

File:

PDF, 370 KB

english, 2015

44

A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 ‘CREATE’ trial

Péron, Julien, Marreaud, Sandrine, Staelens, Dominiek, Raveloarivahy, Tiana, Nzokirantevye, Axelle, Flament, Jocelyne, Steuve, Jonathan, Lia, Michela, Collette, Laurence, Schöffski, Patrick

Journal:

European Journal of Cancer

Year:

2019

Language:

english

File:

PDF, 440 KB

english, 2019

45

Band structure of very narrow InGaAs/InP quantum wells with gradual interface effects

F. Dujardin, N. Marréaud, J.P. Laurenti

Journal:

Superlattices and Microstructures

Year:

1997

Language:

english

File:

PDF, 115 KB

english, 1997

46

Results of Hrqol Data from Palette: A Randomized Double Blind Phase III Trial of Pazopanib Versus Placebo in Metastatic Soft Tissue Sarcoma (STS) Patients. An Eortc Stbsg Global Network Study (EORTC 62072)

Coens, C., van der Graaf, W.T.A., Blay, J., Chawla, S.P., Kim, D., Sanfilippo, R., Manson, S., Ouali, M., Marreaud, S., Bottomley, A.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 60 KB

2012

47

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

O.S. Nielsen, P. Reichardt, T.B. Christensen, D. Pink, S. Daugaard, C. Hermans, S. Marreaud, M. van Glabbeke, J. Blay, I. Judson

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 133 KB

english, 2006

48

Factors affecting the unexpected failure of DCE-MRI to determine the optimal biological dose of the vascular targeting agent NGR-hTNF in solid cancer patients

Ingrid M.E. Desar, Carla M.L. van Herpen, Jack J.A. van Asten, Walter Fiedler, Sandrine Marreaud, Johanna N.H. Timmer-Bonte, Edwin G.W. ter Voert, Antonio Lambiase, Claudio Bordignon, Arend Heerschap,

Journal:

European Journal of Radiology

Year:

2011

Language:

english

File:

PDF, 629 KB

english, 2011

49

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer

Bonnefoi, H., Zaman, K., Debled, M., Fiche, M., Fournier, M., Nobahar, M., Pierga, J-Y, Koch, K.M., Bartlett, J., Zimmer, A., Marreaud, S., Bogaerts, J., Cameron, D.

Journal:

European Journal of Cancer

Year:

2013

Language:

english

File:

PDF, 397 KB

english, 2013

50

Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database study

Verschoor, A.J., Litière, S., Marréaud, S., Judson, I., Toulmonde, M., Wardelmann, E., van der Graaf, W.T., Le Cesne, A., Gronchi, A., Gelderblom, H.

Journal:

European Journal of Cancer

Year:

2018

Language:

english

File:

PDF, 580 KB

english, 2018

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски